Thermo Fisher Scientific updates its Covid-19 panel to detect Omicron
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Expands bioprocessing footprint across Asia
Subscribe To Our Newsletter & Stay Updated